Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03991832
Title Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors (SOLID)
Acronym SOLID
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field